SF 3085 appropriates $300,000 in fiscal year 2026 and $300,000 in fiscal year 2027 from the workforce development fund to the commissioner of employment and economic development for a grant to the Rural Cancer Institute. The grant would support a pilot program aimed at expanding the oncology clinical workforce in rural districts.
The bill directs the program to increase the number of cancer care clinicians serving rural communities and to train health care students in the skills needed to provide cancer care in a rural setting. It emphasizes a community-based model designed to address the shortage of oncology professionals outside metropolitan areas and improve access to cancer care in rural Minnesota.
Impact
The bill creates a one-time appropriation and does not amend substantive health or workforce statutes. Its practical effect would be to redirect workforce development dollars to a targeted grant program supporting rural oncology training and recruitment, administered by the commissioner of employment and economic development. The primary affected parties would be the Rural Cancer Institute, health care students, rural health systems, and patients in rural districts who may benefit from expanded cancer care capacity.
Sentiment
Based on the bill text and available context, the measure appears generally supportive and narrowly targeted, with no recorded votes or committee testimony indicating opposition. The bill’s focus on rural health workforce shortages and cancer care access suggests a policy goal likely to attract bipartisan interest, especially from legislators concerned with rural services and health care staffing. There is no evidence in the available record of significant controversy or amendment activity.
Contention
No formal contention is documented in the available materials. The main policy question implied by the bill is whether a one-time $600,000 appropriation is the most effective way to address rural oncology workforce shortages, and whether the pilot program will produce measurable workforce growth. Any concerns would likely center on funding priorities, program effectiveness, and whether the grant structure can sustainably improve rural cancer care access.